SBI Healthcare Opportunities Fund
Gland Pharma Limited · NSE
6,00,000 sh · ₹150.17 Cr
HDFC Mid Cap Fund
1.4% of their portfolio
₹1,518.71 Cr
60,67,814 sh
SBI Large and Midcap Fund
1.9% of their portfolio
₹793.42 Cr
31,70,000 sh
Nippon India Growth Mid Cap Fund
1.4% of their portfolio
₹700.81 Cr
28,00,000 sh
ICICI Prudential India Opportunities Fund
1.6% of their portfolio
₹601.55 Cr
24,03,430 sh
Nippon India Small Cap Fund
0.6% of their portfolio
₹458.64 Cr
18,32,424 sh
HDFC Large and Mid Cap Fund
1.2% of their portfolio
₹350.41 Cr
14,00,000 sh
Nippon India Multi Cap Fund
0.5% of their portfolio
₹298.81 Cr
11,93,854 sh
SBI Contra Fund
58.0% of their portfolio
₹278.58 Cr
11,13,026 sh
Nippon India ELSS Tax Saver Fund
1.9% of their portfolio
₹275.32 Cr
11,00,000 sh
Nippon India Pharma Fund
2.2% of their portfolio
₹200.37 Cr
8,00,549 sh
SBI Healthcare Opportunities Fund
2.8% of their portfolio
₹150.17 Cr
6,00,000 sh
ICICI Prudential Equity & Debt Fund
0.3% of their portfolio
₹136.20 Cr
6,05,332 sh
FIIs raised their stake +1.4pp QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
SBI Healthcare Opportunities Fund
Gland Pharma Limited · NSE
6,00,000 sh · ₹150.17 Cr
Groww Mutual Fund (scheme XC)
Gland Pharma Limited · NSE
601 sh · ₹15.04 L
SBI Conservative Hybrid Fund
Gland Pharma Limited · NSE
3,18,846 sh · ₹79.80 Cr
Nippon India Nifty 500 Equal Weight Index Fund
Gland Pharma Limited · NSE
4,224 sh · ₹1.06 Cr
HDFC Hybrid Equity Fund
Gland Pharma Limited · NSE
3,50,000 sh · ₹87.60 Cr
HDFC BSE 500 Index Fund
Gland Pharma Limited · NSE
1,289 sh · ₹32.28 L
HDFC Multi Cap Fund
Gland Pharma Limited · NSE
5,17,485 sh · ₹129.52 Cr
SBI Nifty Small Cap 250 ETF
Gland Pharma Limited · NSE
290 sh · ₹7.26 L
ICICI Prudential MNC Fund
Gland Pharma Limited · NSE
2,22,475 sh · ₹55.68 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
39 announcements on record for this company.
Promoter holding by quarter: Jun 2025 51.8%, Sep 2025 51.8%, Dec 2025 51.8%, Mar 2026 51.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.3pp
FII holding by quarter: Jun 2025 7.4%, Sep 2025 7.9%, Dec 2025 7.6%, Mar 2026 7.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— +0.4pp
DII holding by quarter: Jun 2025 32.9%, Sep 2025 32.6%, Dec 2025 33.0%, Mar 2026 33.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— +0.4pp
MF holding by quarter: Jun 2025 30.7%, Sep 2025 30.2%, Dec 2025 31.4%, Mar 2026 31.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Groww Mutual Fund (scheme XK)
Gland Pharma Limited · NSE
706 sh · ₹17.67 L
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 51.8%, Sep 2025 51.8%, Dec 2025 51.8%, Mar 2026 51.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.3pp
FII holding by quarter: Jun 2025 7.4%, Sep 2025 7.9%, Dec 2025 7.6%, Mar 2026 7.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— +0.4pp
DII holding by quarter: Jun 2025 32.9%, Sep 2025 32.6%, Dec 2025 33.0%, Mar 2026 33.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— +0.4pp
MF holding by quarter: Jun 2025 30.7%, Sep 2025 30.2%, Dec 2025 31.4%, Mar 2026 31.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
39 announcements on record for this company.